Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Chao

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Leukemia Research|June 11, 2020
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I studyAaron D Goldberg, Ehab Atallah, David Rizzieri, et al.
Human Mutation|July 26, 2019
Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classificationMelissa A Gilbert, Robert C Bauer, Ramakrishnan Rajagopalan, et al.
The Journal of Biological Chemistry|April 6, 2025
Catalytically distinct metabolic enzyme isocitrate dehydrogenase 1 mutants tune phenotype severity in tumor modelsAshley V Schwartz, Grace Chao, Mikella Robinson, et al.
Journal of Medical Genetics|January 3, 2012
NOTCH2 mutations in Alagille syndromeBinita Maya Kamath, Robert C Bauer, Kathleen M Loomes, et al.
Nature Materials|March 25, 2025
Tension anisotropy drives fibroblast phenotypic transition by self-reinforcing cell-extracellular matrix mechanical feedbackFarid Alisafaei, Delaram Shakiba, Yuan Hong, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Leukemia Research|June 11, 2020
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I studyAaron D Goldberg, Ehab Atallah, David Rizzieri, et al.
Human Mutation|July 26, 2019
Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classificationMelissa A Gilbert, Robert C Bauer, Ramakrishnan Rajagopalan, et al.
The Journal of Biological Chemistry|April 6, 2025
Catalytically distinct metabolic enzyme isocitrate dehydrogenase 1 mutants tune phenotype severity in tumor modelsAshley V Schwartz, Grace Chao, Mikella Robinson, et al.
Journal of Medical Genetics|January 3, 2012
NOTCH2 mutations in Alagille syndromeBinita Maya Kamath, Robert C Bauer, Kathleen M Loomes, et al.
Nature Materials|March 25, 2025
Tension anisotropy drives fibroblast phenotypic transition by self-reinforcing cell-extracellular matrix mechanical feedbackFarid Alisafaei, Delaram Shakiba, Yuan Hong, et al.
Pageof 7